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Abstract
Objective—African American men have higher prostate cancer incidence rates than White men,
for reasons not completely understood. This review summarizes the existing literature of race-
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specific associations between risk factors and prostate cancer in order to examine whether
associations differ.
Methods—We reviewed epidemiologic studies published between January 1970 and December
2008 that reported race-specific effect estimates. We focused mainly on modifiable risk factors
related to lifestyle and health. A total of 37 articles from 21 study populations met our inclusion
criteria.
Results—We found no evidence of racial differences in associations between prostate cancer and
alcohol intake, tobacco use, and family history of prostate cancer. Research suggests that a modest
positive association may exist between height and prostate cancer risk (all prostate cancer and
advanced prostate cancer) among Whites only. No clear patterns were observed for associations
with physical activity, weight/body mass index, dietary factors, occupational history, sexual
behavior, sexually transmissible infections, and other health conditions.
Discussion—Our results suggest few differences in prostate cancer risk factors exist between
racial groups and underscore areas where additional research is needed. Future studies should
enroll higher numbers of African American participants and report results for advanced prostate
cancer.
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Prostate cancer; Epidemiology; Review; Race; African American
Introduction
Prostate cancer is the most common malignancy affecting men in the United States (US) [1].
Following cancer of the lung and bronchus, it is the second leading cause of cancer-related
death among men in the US [1]. African Americans have higher prostate cancer incidence
rates than Whites. According to data from the Surveillance, Epidemiology, and End Results
(SEER) program, age-adjusted prostate cancer incidence rates from 2002 to 2006 for White
and African American men were 153.0 and 239.8 per 100,000 persons, respectively [2].
Incidence rates have decreased over the last few years among both White and African
American men, but the large disparity between the two racial groups remains prominent [2].
Furthermore, a higher percentage of prostate cancers are diagnosed at advanced stages
among African American men (6% at distant stages) compared to Whites (4% at distant
stages) [3].
In addition to race/ethnicity, age and family history of prostate cancer are the only
established risk factors for prostate cancer [4, 5]. Specifically, 63% of diagnosed prostate
cancer cases occur in men aged 65 years and older [4], and men with an affected father or
brother are approximately twice as likely to develop the disease themselves [6]. A wide
range of additional factors have been examined as potential risk factors for prostate cancer
[7, 8], but none have produced definitive evidence of an association.
Given the wide disparity that exists between White and African American men in terms of
prostate cancer incidence, it is of great interest to examine how associations between
possible risk factors and prostate cancer risk may differ by racial group. To our knowledge,
a comprehensive review describing these potential differences does not exist. The aim of
this report was to summarize the existing literature addressing race-stratified associations
between risk factors and prostate cancer, focusing primarily on modifiable lifestyle and
health-related factors. We examined these factors’ associations with all prostate cancer, as
well as advanced prostate cancer occurrence. Results will be useful for identifying potential
racial differences in prostate cancer risk factors and underscoring areas in which future
research is needed.
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We conducted a literature review using PubMed, identifying references published between
January 1970 and December 2008 that reported race-specific effect estimates for potential
prostate cancer risk factors. The literature search centered around the keywords of “prostate
cancer” and “race” in PubMed.
Two study authors (IM and PR) independently reviewed the titles, abstracts, and articles (if
appropriate) of studies identified in the search to determine if each met the following
inclusion criteria: (1) report written in English; (2) study conducted in the US; and (3) study
reported race-specific effect estimates (articles providing only p-values were excluded). We
also identified and reviewed articles referenced in these studies for possible inclusion.
Studies conducted among only African Americans were included, provided they met all
other inclusion criteria. We excluded studies that did not include African Americans or
investigated only genetic or demographic risk factors, as we chose to focus primarily on
more modifiable risk factors related to lifestyle and health. We also excluded review articles
and unpublished studies and abstracts.
A total of 37 articles from 21 different study populations met the inclusion criteria for this
review (Table 1). The majority of articles (n = 35, 95%) included both African American
and White men, while two reports (5%) included only African Americans. We abstracted the
first author, study characteristics, race-specific sample sizes, and race-specific effect
estimates for each study. Effect estimates and corresponding confidence intervals (if
reported) abstracted from the reviewed articles for all prostate cancer cases are displayed in
ESM Table S1, while Table 2 contains these data for advanced prostate cancers only. The
definition of advanced prostate cancer differed somewhat between studies but was based on
cancer stage (i.e., regional/distant cases) and/or grade (i.e., cells were poorly differentiated)
in all instances. For the sake of simplicity, we refer to all as advanced prostate cancer cases
in this review. Both tables are categorized by potential risk factor. If confidence intervals
were not reported, we report p-values if provided or just effect estimates in cases where
neither confidence intervals nor p-values were reported. We report covariate-adjusted effect
estimates if they were provided in the original manuscript, and report unadjusted estimates
otherwise.
Results
All prostate cancer cases
Anthropometric measures—Eight studies examined associations between
anthropometric variables and prostate cancer and reported race-specific effect estimates
[9-16]. Height was addressed in two of these studies, a population-based case–control study
and a large prospective cohort study. Neither showed an association between height and
prostate cancer risk among African Americans. However, both studies reported a modest
increased risk among the tallest Whites, with effect estimates ranging from 1.2 to 1.7 [10,
11].
All eight studies addressed weight, body mass index (BMI), or obesity. Four of these,
including a large prospective cohort study and a case–control study nested in a prospective
cohort, reported no association with body mass or weight among either racial group [11, 12,
14, 16]. Two case–control studies, one hospital-based and one population-based, did report
elevated risk of prostate cancer among Whites, but not African Americans, with either
higher current body mass or higher body mass at their maximum weight [9, 10]. However,
no clear dose–response trend was apparent in the study focusing on current body mass [9].
Clinically diagnosed obesity (ICD8 = 277; ICD9 = 278.0) was examined in a very large
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cohort with similar weak associations found among Whites (relative risk (RR), 1.19; 95%
confidence interval (CI), 1.15–1.24) and African Americans (RR, 1.12; 95% CI, 1.04–1.20)
[13].
A small study including only African Americans reported that waist circumference of
greater than 102 cm was positively associated with prostate cancer risk relative to waist
circumference of 102 cm or smaller (odds ratio (OR), 1.84; 95% CI, 1.17–2.91) [15]. Self-
reported anthropometric measurements during childhood were examined in one study, with
results suggesting that White men who recalled being taller (ptrend = 0.0009) and heavier
(ptrend = 0.04) during childhood had increased risk of prostate cancer [10]. Such trends were
not observed among African Americans in this study, despite similar sample sizes between
the racial groups.
Tobacco use—Four studies examined race-stratified associations between smoking and
prostate cancer [9, 12, 17, 18]. Of these, a small case–control study did not find an
association with history of cigarette smoking (ever vs. never) among either race [17]. Two
larger studies examined both former and current smoking relative to never smoking and
found null or weak positive associations; results did not appear to differ by racial group [12,
18]. The fourth, a hospital-based investigation, suggested positive associations between
prostate cancer and both former (OR = 1.4) and current smoking (OR = 1.7) among African
Americans only [9].
Two studies examined associations between duration and intensity of cigarette smoking and
prostate cancer risk [12, 18]. One study found positive associations among those who
reported smoking 40 or more cigarettes per day for both African Americans (former
smokers: OR, 1.1; 95% CI, 0.6–2.0; current smokers: OR, 1.9; 95% CI, 0.9–4.2) and Whites
(former smokers: OR, 1.5; 95% CI, 1.0–2.2; current smokers: OR, 1.3; 95% CI, 0.7–2.4)
[18]. The other, smaller study reported no associations with smoking amount or duration
among either race [12]. Use of pipes, cigars, snuff, and chewing tobacco was examined in
one investigation, finding a positive, but very imprecise, association between current snuff
use and prostate cancer risk among African Americans (OR, 4.7; 95% CI, 0.9–24.7) [18].
Alcohol use—Four studies reported race-stratified results when examining associations
between alcohol intake and prostate cancer risk [9, 12, 17, 19]. Two small case–control
investigations reported no evidence of an association among either race [12, 17], and a
larger study found weak associations among African Americans (OR, 1.2; 95% CI, 0.9–1.7)
and Whites (OR, 1.2; 95% CI, 0.9–1.7) when comparing those who reported any alcohol
intake to those who never drank [19]. A hospital-based study that looked at alcohol
consumption also found weak positive associations among both races [9].
When alcohol consumption was examined in a more detailed manner, one investigation
reported the odds of prostate cancer were elevated for men who had 57 or more drinks per
week (African Americans: OR, 1.8; 95% CI, 1.1–3.0; Whites: OR, 2.0; 95% CI, 1.2–3.4)
[19]. Similar risk patterns for increased consumption were apparent when beer, liquor, and
wine were examined individually [19]. A more recent, much smaller study failed to replicate
these findings when examining number of drinks per day, with the highest level of
consumption defined as five or more drinks per day [12].
Physical activity—Five studies presented race-stratified results for physical activity [9,
10, 12, 16, 20]. A hospital-based investigation reported that both African Americans and
Whites with low or moderate levels of physical activity had a slightly increased risk of
prostate cancer compared to men who were more active [9]. Three population-based case–
control studies found no association between physical activity and prostate cancer in either
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race [10, 12, 16]. A prospective cohort investigation reported that, among African
Americans, low physical activity levels were associated with elevated prostate cancer risk
(non-recreational: RR, 3.74; 95% CI, 1.66–8.44; recreational: RR, 3.17; 95% CI, 0.96–
10.46) [20]. However, only 47 African American cases were included in this study and the
confidence intervals for effect estimates were wide [20]. These patterns were not observed
among Whites [20].
General health—Four investigations examined associations between diabetes and prostate
cancer [15, 21-23]. A small hospital-based study found an inverse association among Whites
(OR, 0.44; 95% CI, 0.21–0.93) and a positive effect among African Americans (OR, 3.16;
95% CI, 0.67–15.0), with the interaction between race and diabetes status reaching statistical
significance (p < 0.05) [21]. A small case–control study found an inverse association among
African Americans (OR, 0.36; 95% CI, 0.21–0.62) but not Whites (OR, 1.08; 95% CI, 0.66–
1.78) [22], and another small study conducted among African Americans only found no
relation between diabetes and prostate cancer occurrence (OR, 0.96; 95% CI, 0.55–1.68)
[15]. Finally, a large prospective cohort investigation found some evidence of an inverse
association among both African Americans (RR, 0.59; 95% CI, 0.37–0.95) and Whites (RR,
0.82; 95% CI, 0.63–1.08) [23].
Two studies examined associations between blood pressure and prostate cancer risk [15, 24].
A large prospective cohort study found an inverse association with high blood pressure
among both African Americans (RR, 0.82; 95% CI, 0.66–1.02) and Whites (RR, 0.88; 95%
CI, 0.78–0.98) [24]. A subsequent smaller case–control study examining only African
Americans reported a positive association between self-reported high blood pressure and
prostate cancer risk (OR, 2.36; 95% CI, 1.49–3.73) [15].
Heart rate [24], aspirin use [25], use of thiazolidinediones [26], male pattern baldness [27],
and prostate conditions (history of benign prostatic hyperplasia (BPH) and prostatitis) [28]
were examined in one study each. Among both races, use of thiazolidinediones showed a
weak positive association [26], aspirin use (defined as intake of 6 or more aspirin almost
every day) showed a weak, non-significant inverse association [25], and heart rate showed
no evidence of an association with prostate cancer risk [24]. Male pattern baldness was
correlated with prostate cancer occurrence among both African Americans (RR, 2.10; 95%
CI, 1.04–4.25) and Whites (defined as anyone who was not African American; RR, 1.42;
95% CI, 1.01–1.98) in a cohort study [27]. A history of BPH was associated with increased
risk among both races in a small case–control study, but history of prostatitis showed
evidence of increased risk only among African Americans [28].
Diet—A wide range of dietary factors has been examined for associations with prostate
cancer risk in race-stratified analyses [10, 12, 16, 17, 29-33]. Only one study assessed the
total number of calories from food and reported an elevated risk among those in the upper
quartiles of daily caloric intake compared to the lowest quartile among both African
Americans (OR range, 1.5–1.8) and Whites (OR range, 1.3–1.7) [10]. When looking at fruit
and vegetable intake, little effect on prostate cancer occurrence has been observed [10, 17,
29].
Two studies, a case–control study and a cohort investigation, reported an increase in prostate
cancer occurrence among African Americans with higher levels of red meat intake, but not
among Whites [10, 32]. For example, Hayes et al. [10] reported that African American men
in the highest quartile of red meat intake had 1.9 times the odds of prostate cancer compared
to men in the lowest quartile (p < 0.05). However, a more recent prospective cohort study
with more African American participants but fewer White participants failed to find
associations between red meat intake and prostate cancer in either racial group [33]. African
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American men with higher levels of either pork (RR, 2.3; p < 0.05) or beef or pork kidney
(RR, 2.8; p < 0.05) consumption had increased prostate cancer occurrence in a small case–
control study [17]. Poultry intake, on the other hand, showed an inverse association among
both Whites (RR, 0.4; p < 0.05) and African Americans (RR, 0.4; p < 0.01) [17], but a
subsequent cohort study failed to replicate these findings [32]. The latter study, however,
contained fewer African American cases.
Fat intake has also been examined in multiple studies, producing inconsistent results [10, 12,
16, 17, 33]. One case–control study reported a positive association between higher dietary
fat intake and prostate cancer among both races [10]. For example, both African American
(OR range, 1.5–2.0) and White (OR range, 1.2–1.7) men in quartiles 2–4 of animal fat intake
had higher prostate cancer risk compared to those in the lowest quartile [10]. In a smaller
study, Ross and colleagues found similar positive associations between higher dietary fat
intake and prostate cancer occurrence among White and African American men, but only the
association in African American men reached statistical significance [17]. Additional
studies, including a large cohort study, have reported no association in either racial group
when looking at dietary fat intake as a risk factor [12, 16, 33].
Many additional dietary factors have been associated with prostate cancer risk, though
findings are primarily from one study only or are inconsistent among a small number of
studies. For instance, higher protein intake was associated with prostate cancer among
African Americans (OR range, 1.4–1.8), but not Whites, in one study [10], while a smaller
study reported no association among either racial group [17]. Lycopene intake has been
addressed in three studies [10, 12, 30], with one reporting reduced risk among Whites only
(≥8.1 servings per week vs. ≤2.6 servings per week: OR, 0.55; p < 0.05) [12]. Prostate
cancer occurrence has been associated with higher consumption of β-carotene [30] and eggs
[17] and lower consumption of legumes [29] among African Americans. Among Whites,
higher intake levels of eggs [17] and dairy foods [10] have been positively associated with
prostate cancer. Serum levels of selenium were examined in one study, with non-significant
trends reported among both races [31].
Family history of cancer—Family history of prostate cancer is an established risk factor
for the disease [4] and has been examined in a race-stratified manner in five investigations
[12, 34-37]. All reported an increased risk of prostate cancer among those with a positive
family history [12, 34-37]. Family history of prostate cancer in any first-degree blood
relative has been shown to increase risk similarly for men of both racial groups [12, 34-36].
For example, both African American (OR, 3.4; 95% CI, 1.5–7.5) and White (OR, 3.1; 95%
CI, 1.8–5.3) men with a family history of prostate cancer had over three times the odds of
prostate cancer compared to those without an affected first-degree relative in a study by
Hayes and colleagues [34].
The association between affected relative type and prostate cancer risk has been examined in
more detail in some investigations, and family history of other cancers has also been
assessed as a potential risk factor for prostate cancer. One study showed an increase in risk
among White men with an affected second-degree relative (OR, 4.44; p < 0.05) [12], though
a larger study did not find this association [35]. Prostate cancer occurrence was higher
among men with an affected brother in a small study comprised of only African Americans
(OR, 4.80; 95% CI, 2.01–11.44) [37]. Family history of other cancers has mostly produced
no association with prostate cancer risk [34, 37], although one small study including only
African Americans reported that having a sister with a history of breast cancer was
positively associated with prostate cancer occurrence (OR, 3.80; 95% CI, 1.57–9.22) [37].
Mordukhovich et al. Page 6













Occupation—Multiple studies have addressed occupation as a potential risk factor for
prostate cancer using various job title and industry classifications [9, 12, 17, 38, 39]. Yu and
colleagues found an increased prostate cancer risk among White men with professional
occupations in a hospital-based investigation (OR, 1.8; 95% CI, 1.5–2.1) [9]. Krstev et al.
examined a large number of occupations but reported no clear patterns of risk when
comparing racial groups or white-collar jobs to blue-collar jobs [38]. Interestingly, farming
was shown to increase risk of prostate cancer among White men in two studies (ORs: 1.8–
2.7) [38, 39]; the larger study also found some evidence of an association among African
Americans (OR, 1.97; 95% CI, 0.91–4.25) [38].
Specific occupational exposures have also been examined in a few investigations [17, 39].
Exposure to cadmium was not associated with prostate cancer among men of either race in a
small case–control study [17]. Meyer et al. focused on exposures common to farming and
reported that White farmers who reported ever mixing or applying pesticides had increased
odds of prostate cancer compared to non-farmers (OR, 1.8; 95% CI, 1.2–2.7) [39]. The
results were also suggestive of a weakly increased risk among the smaller sample of African
American men (OR, 1.2; 95% CI, 0.8–2.0) [39]. Farmers who reported never picking cotton
(both races) or never harvesting tobacco (White men only) also had increased risk of
prostate cancer compared to men who were not farmers in this study [39].
Sexual health and behavior—Ten studies reported race-stratified effect estimates when
examining associations between sexual behaviors or sexually transmitted infections (STIs)
and prostate cancer risk [12, 14, 17, 28, 40-45]. Three of these studies looked at associations
with history of any STI, of which one found no relation among either race [28], one found
positive associations among both Whites (RR, 2.3; p > 0.05) and African Americans (RR,
1.7; p < 0.05) [17], and one found a weak positive relation among Whites only (OR, 1.3;
95% CI, 1.0–1.6) [45]. Two studies also examined STI frequency and found no overall
relation with prostate cancer occurrence [28, 45], although White men with a history of three
past STIs had an increased risk compared to men with no history of STI (OR, 1.7; 95% CI,
1.1–2.6) in a nested case–control study [45].
Three studies examined associations between human papillomavirus (HPV) infection and
prostate cancer risk [42, 43, 45]. HPV status was determined by either serological or viral
DNA evidence of HPV infection. One of these investigations, a very small study using BPH
controls and testing for HPV types 6, 11, 16, 18, 31, 33, and 45, found positive, but
imprecise associations between the presence of any HPV type and prostate cancer for
African Americans (OR, 1.50; 95% CI, 0.14–15.59) and Whites (OR, 1.72; 95% CI, 0.34–
8.76) [42]. A larger population-based investigation (testing for antibodies to HPV type 16)
reported a positive association among Whites only (OR, 1.8; 95% CI, 0.7–4.9) [43], and the
third study (testing for HPV types 16 and 18) found no associations among either race [45].
Herpes virus (herpes simplex virus [HSV] 1 and 2, human herpesvirus 8) has also been
examined in multiple studies with no evidence of a relation with prostate cancer among
either race [28, 44, 45].
Four investigations examined associations between gonorrhea and prostate cancer [12, 28,
43, 45]. Results were either null or weakly positive with no indication of consistent racial
differences [12, 28, 43, 45]. Two studies evaluated frequency of gonorrhea infection, one of
which found a positive trend among African Americans (p = 0.0003) [43]. The other,
smaller study failed to find such a trend [28]. For syphilis, one investigation found positive
associations among both African Americans (OR, 2.4; 95% CI, 1.2–4.9) and Whites (OR,
2.8; 95% CI, 0.2–49.1) [43], though the latter association was imprecise. Three additional
studies found no evidence of an association between syphilis and prostate cancer in either
race [12, 28, 45]. In examining gonorrhea and syphilis infection as potential risk factors,
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studies often lacked sufficient sample size to calculate effect measures for Whites due to low
prevalence of infection.
Other STIs have been examined as potential risk factors in one study each. Chancroid and
cytomegalovirus infection were not associated with prostate cancer among either White or
African American men [28, 45]. Serological evidence of Chlamydia (IgA) was related to
prostate cancer risk among African Americans only (OR, 2.1; 95% CI, 1.2–3.6) [45].
Two case–control studies examined vasectomy with neither observing associations with
prostate cancer among Whites and one finding an elevated non-significant relation for self-
reported history of vasectomy among African Americans (OR, 1.6; 95% CI, 0.5–4.8) [40,
41]. No consistent patterns emerged when examining age at vasectomy or years since
vasectomy [40, 41], although one study reported an increased risk among Whites who were
25–34 years old at the time of their vasectomies (OR, 2.2; 95% CI, 1.0–4.4) [40].
The following potential risk factors were examined in one study each: number of marriages,
number of children, age at first sexual intercourse, frequency of sexual intercourse, number
of female sexual partners, sexual intercourse with prostitutes, condom use, levels of sex
hormones, and circumcision [14, 17, 43]. Circumcision was inversely associated with
prostate cancer among both racial groups [17], while condom use was inversely associated
only among African Americans [43]. The number of sexual encounters with prostitutes and
sex hormone levels were positively associated with prostate cancer among only Whites [14,
43].
Advanced prostate cancer
Only seven studies reported race-stratified effect estimates for risk factors and advanced
prostate cancer, with each risk factor addressed in only 1 or 2 studies (Table 2) [10, 16, 19,
21, 23, 32, 34]. Overall, studies tended to report comparable results for advanced prostate
cancer as they did for all prostate cancer cases combined. Greater height was associated with
increased risk for advanced prostate cancer among Whites (OR range: 2.1–2.2) but not
among African Americans (OR range: 0.8–1.1) [10]. Positive associations involving
perceived anthropometric measurements (height and weight) during childhood were also
only present among Whites [10]. Heavy alcohol use (57 or more drinks per week) was
correlated with increased risk of advanced prostate cancer among both African Americans
(OR, 2.0; 95% CI, 1.1–3.6) and Whites (OR, 2.1; 95% CI, 1.1–3.8) [19]. For diabetes, a
small hospital-based study found an inverse association among Whites (OR, 0.27; 95% CI,
0.11–0.71) and was suggestive of a positive effect among African Americans (OR, 2.74;
95% CI, 0.55–13.5) [21]. A larger cohort study did not find an association between glucose
tolerance and advanced prostate cancer among either race [23]. A family history of prostate
cancer was correlated with higher risk of advanced prostate cancer among both African
Americans (OR, 3.4; 95% CI, 1.3–9.3) and Whites (OR, 2.1; 95% CI, 0.9–4.5) [34].
Dietary results for advanced prostate cancer also tended to be similar to those reported for
all prostate cancer cases. One study found statistically significant trends involving intake of
meat (OR range: 1.6–2.4), red meat (OR range: 1.7–2.5), and protein (OR range: 2.1–2.9)
with advanced prostate cancer among African Americans, but not among Whites [10]. This
same study reported positive associations for intake of fat and animal fat among men of both
races [10]. Total number of calories was also positively associated with higher risk of
advanced prostate cancer among both races, though only the results for African American
men reached statistical significance [10].
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African Americans have higher prostate cancer incidence rates than Whites in the US [2]. In
this report, we reviewed the existing literature addressing race-specific associations between
potential risk factors and prostate cancer. These associations could vary by race due to
differences in prostate tumor biology [46, 47], risk factor prevalence, and characteristics
between racial groups. For example, in the US, there is a higher prevalence of obesity
among African Americans relative to Whites [48]. While many studies reported race-
specific associations for all prostate cancer cases, few reported such associations for
advanced prostate cancer cases. It is important to examine and report results for advanced
prostate cancer since a higher percentage of prostate cancers are diagnosed at advanced
stages for African American men compared to Whites [3]. Findings from our review not
only summarize what is currently known about racial differences in prostate cancer risk
factors but also underscore areas where future research is needed.
No clear pattern of differences by racial group was observed among studies evaluating
associations between prostate cancer and physical activity, weight/BMI, diet, occupational
history, sexual behavior, STIs, and other health conditions. The current literature suggests
that alcohol and tobacco use may not be important risk factors for prostate cancer among
either African Americans or Whites, though there is some evidence of an association among
both races at very high levels of exposure for both risk factors. High levels of alcohol use
may also increase the risk of advanced prostate cancer among both racial groups. Consistent
associations between family history of prostate cancer and risk of disease (all prostate cancer
and advanced prostate cancer) were found among both racial groups. Research also suggests
modest positive associations may exist between height and prostate cancer risk (all prostate
cancer and advanced prostate cancer) among Whites only. It has been suggested that height
may be related to prostate cancer through the insulin-like growth factor system [49].
There are a number of issues that should be considered when interpreting results from the
studies included in this review. First, the statistical power to detect associations was likely
lower for African Americans than Whites due to smaller sample sizes. Across all 37
manuscripts, the median number of White prostate cancer cases was 494, compared to only
166 African Americans cases. Under-representation of minority populations in research
studies is well recognized [50, 51], and continued efforts are needed among these
populations to increase their participation in future epidemiologic and clinical studies.
Detection bias may have affected studies examining associations between prostate cancer
and weight-related variables, family history of prostate cancer, diabetes, blood pressure, and
vasectomy. Obese individuals are likely to have other medical conditions requiring regular
medical visits, which may lead to an increased chance of prostate cancer detection [52]. Men
with a family history of prostate cancer are more likely to utilize prostate cancer screening
[53], which could also lead to increased detection. Results concerning blood pressure and
diabetes may be affected by detection bias since men undergoing increased medical care for
these conditions may be more likely to be screened for prostate cancer [52]. Likewise,
vasectomy may increase the chance for incidental discovery of a prostate malignancy [54].
Misclassification bias may have affected studies examining associations between prostate
cancer and weight-related variables, physical activity, diet, alcohol intake, tobacco use,
sexual behavior, STIs, diabetes, family history of prostate cancer, and blood pressure. This
may be due to inadequate recall of relevant information that may be exacerbated by the
memory problems common among older men, the group most affected by prostate cancer
[4]. Blood pressure and diabetes were self-reported in some studies (1 of 2 for blood
pressure, and 3 of 4 for diabetes), which may cause either differential or nondifferential
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misclassification [55]. Data on obesity and other body measurements were collected using
various methods (self-report, trained personnel taking measurements, clinical diagnosis) and
analyzed in different formats (dichotomously, quintiles, etc.). Likewise, data on STIs were
obtained differently both across and within investigations (self-report, serological
assessment, measurement of viral DNA in prostatic tissues). All five studies addressing
family history of cancer relied on self-reported information and only two [35, 36] attempted
to verify these data. This is concerning since self-reported family histories of prostate cancer
have been shown to contain inaccuracies [56, 57].
It is also possible that reporting of certain health behaviors differed by racial group and that
some data collection instruments were not ideal for all participants. For example, research
has shown that African Americans underreport tobacco use more frequently compared to
Whites [58]. Furthermore, some studies used food frequency questionnaires or diet histories
that were not modified for local diet and did not incorporate racial differences in dietary
habits. Both potential limitations could lead to measurement error, which may be
particularly problematic for those studies that relied solely upon self-reported data.
There was inconsistency between studies in controlling for potential confounders. Age and
family history of prostate cancer are two established risk factors for prostate cancer [4, 5].
Although almost all studies controlled for age, few controlled for family history of prostate
cancer. Additionally, few studies accounted for prostate cancer screening history (e.g.,
prostate-specific antigen [PSA] testing), which is important since PSA testing may differ by
race [59, 60] and such testing has led to a large increase in the incidence of prostate cancer
in the US [61]. Many of these detected cancers are slow-growing and would not lead to
clinical manifestations of disease [62].
Our review has several strengths including the direct examination of risk factors for total
and advanced prostate cancer and that almost all studies recruited both African Americans
and Whites. We believe such studies allow for more direct, and possibly more valid, racial
comparisons of reported associations. Our review was also limited by a number of factors.
Specifically, we did not examine race-specific associations for screening patterns, genetic
variants, or demographic factors. In addition, this review was qualitative in nature, as we did
not perform quantitative analyses of the abstracted data. For advanced prostate cancer, we
present and discuss data from various studies that used slightly different definitions of
advanced prostate cancer. Finally, we did not include studies that were comprised of only
Whites or did not report race-specific associations. However, the results we report for
Whites appear to be consistent with the overall prostate cancer literature [1, 7].
We found no evidence of racial differences in associations between prostate cancer and
alcohol intake, tobacco use, and family history of prostate cancer. Research suggests a
modest positive association may exist between height and prostate cancer risk (all prostate
cancer and advanced prostate cancer) among Whites only. No clear patterns were discernible
among studies evaluating associations between prostate cancer and physical activity, weight/
BMI, dietary factors, occupational history, sexual behavior, STIs, and other health
conditions. These findings summarize what is currently known about racial differences in
prostate cancer risk factors and highlight areas where future research is needed. As
demonstrated by this review, enrolling higher numbers of African American participants and
examining how risk factors affect both total prostate cancer occurrence and advanced
prostate cancer occurrence will be extremely important in advancing this field of research.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 2




 Hayes, 1999 Height (meters, category medians displayed)
 1.67 1.0 (ref.) 1.0 (ref.)
 1.75 1.0 (0.6, 1.6) 2.2 (1.2, 4.2)
 1.80 1.1 (0.7, 1.8) 2.2 (1.2, 4.2)
 1.85 0.8 (0.5, 1.4) 2.1 (1.1, 3.9)
 p (trend) 0.66 0.03
Adult weight, BMI, obesity
 Hayes, 1999 BMI at 25 years of age (category medians displayed)
 19.7 1.0 (ref.) 1.0 (ref.)
 21.8 1.1 (0.7, 2.0) 0.9 (0.5, 1.6)
 23.6 0.8 (0.5, 1.5) 0.8 (0.4, 1.3)
 26.5 1.8 (1.0, 3.0) 1.2 (0.7, 2.0)
 p (trend) 0.03 0.49
BMI at usual adult weight (category medians displayed)
 21.9 1.0 (ref.) 1.0 (ref.)
 24.3 0.8 (0.5, 1.2) 1.0 (0.5, 1.7)
 25.8 0.6 (0.3, 1.0) 1.3 (0.7, 2.2)
 28.9 0.9 (0.5, 1.4) 1.3 (0.8, 2.3)
 p (trend) 0.58 0.20
BMI at maximum weight (category medians displayed)
 23.9 1.0 (ref.) 1.0 (ref.)
 26.5 0.7 (0.5, 1.3) 1.2 (0.7, 2.1)
 29.1 0.7 (0.4, 1.2) 1.6 (1.0, 2.8)
 32.8 0.8 (0.5, 1.2) 1.5 (0.9, 2.7)
 p (trend) 0.30 0.09
Perceived childhood anthropometric measurements
 Hayes, 1999 Perceived childhood height
 Short 1.0 (ref.) 1.0 (ref.)
 Somewhat short 1.1 (0.5, 2.4) 1.0 (0.4, 2.6)
 Average height 0.9 (0.6, 1.6) 1.6 (0.9, 2.7)
 Somewhat Tall 1.1 (0.5, 2.6) 2.4 (1.1, 5.4)
 Tall 1.0 (0.5, 2.0) 1.8 (0.8, 4.0)
 p (trend) 0.97 0.04
Perceived childhood weight
 Thin 1.0 (ref.) 1.0 (ref.)
 Somewhat thin 1.0 (0.5, 1.8) 1.6 (0.9, 2.9)
 Average weight 1.1 (0.7, 1.7) 1.6 (1.0, 2.6)













Mordukhovich et al. Page 18
Study Exposure Results
African American White
 Somewhat heavy 1.3 (0.7, 2.4) 1.1 (0.5, 2.6)
 Heavy 0.9 (0.3, 2.7) 4.0 (1.5, 10.5)
 p (trend) 0.56 0.02
Alcohol use
 Hayes, 1996 Alcohol use
 None 1.0 (ref.) 1.0 (ref.)
 ≥57 drinks per week 2.0 (1.1, 3.6) 2.1 (1.1, 3.8)
Physical activity
 Hayes, 1999 Occupational physical activity
 Sedentary 1.0 (ref.) 1.0 (ref.)
 Moderate 0.9 (0.6, 1.4) 1.1 (0.7, 1.7)
 Active 1.4 (0.9, 2.3) 1.8 (1.0, 3.3)
Diabetes
 Rosenberg, 2002 Diabetes
 No 1.0 (ref.) 1.0 (ref.)
 Yes 2.74 (0.55, 13.5) 0.27 (0.11, 0.71)
 Darbinian, 2008* Glucose tolerance (mg/dL)
 <140 1.0 (ref.) 1.0 (ref.)
 140–159 0.85 (0.52, 1.39) 0.83 (0.58, 1.17)
 160–199 0.95 (0.64, 1.43) 1.09 (0.84, 1.42)
 ≥200 1.07 (0.70, 1.64) 1.02 (0.77, 1.33)
 Diabetes 0.79 (0.36, 1.77) 0.63 (0.34, 1.20)
 p (trend) 0.97 0.96
Fruits and vegetables
 Hayes, 1999 Fruits
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.5 0.9
 Quartile 3 1.4 0.7
 Quartile 4 1.6 0.6
 p (trend) 0.12 0.06
Vegetables
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.3 0.8
 Quartile 3 1.4 0.9
 Quartile 4 1.4 0.9
 p (trend) 0.24 0.79
Raw tomatoes
 0 servings 1.0 (ref.) 1.0 (ref.)
 1–3 servings per month 0.5 0.5
 1 serving per week 0.7 1.2
 2–4 servings per week 0.8 0.8
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 5 + servings per week 0.5 (p < 0.05) 0.5
 p (trend) 0.19 0.13
Cooked tomatoes and tomato sauces
 0 servings 1.0 (ref.) 1.0 (ref.)
 1–3 servings per month 1.7 1.7
 1 serving per week 1.5 1.2
 2–4 servings per week 1.8 1.4
 5 + servings per week 1.9 0.7
 p (trend) 0.57 0.32
Tomato juice
 0 servings 1.0 (ref.) 1.0 (ref.)
 1–3 servings per month 0.8 1.1
 1 serving per week 0.9 1.1
 2–4 servings per week 0.9 1.3
 5 + servings per week 0.2 2.8 (p <0.05)
 p (trend) 0.07 0.02
Watermelon
 0 servings 1.0 (ref.) 1.0 (ref.)
 1–3 servings per month 0.8 0.6 (p <0.05)
 1 Serving Per Week 0.9 0.4
 2–4 Servings Per Week 1.0 0.6
 p (trend) 0.89 0.29
Meat and poultry
 Hayes, 1999 Meat
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.6 1.4
 Quartile 3 2.1 (p < 0.05) 1.0
 Quartile 4 2.4 (p < 0.05) 1.4
 p (trend) 0.002 0.56
Red meat
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.7 1.7
 Quartile 3 1.8 (p < 0.05) 1.6
 Quartile 4 2.5 (p < 0.05) 1.5
 p (trend) 0.0008 0.34
Poultry and fish
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 0.8 1.0
 Quartile 3 1.2 0.9
 Quartile 4 1.1 0.8
 p (trend) 0.29 0.33
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 Rodriguez, 2006* Total processed plus unprocessed red meat (grams per
week)
 0– <246 – 1.0 (ref.)
 246– <408 – 0.9 (0.6, 1.4)
 408– <657 – 1.1 (0.7, 1.6)
 ≥657 – 0.8 (0.5, 1.3)
 p (trend) – 0.53
Unprocessed red meat (grams per week)
 0– <137 – 1.0 (ref.)
 137– <244 – 0.7 (0.5, 1.2)
 244– <423 – 0.9 (0.6, 1.4)
 ≥423 – 0.8 (0.5, 1.2)
 p (trend) – 0.39
Processed meat (grams per week)
 0– <59 – 1.0 (ref.)
 59– <129 – 1.2 (0.9, 1.8)
 129– <247 – 1.2 (0.8, 1.7)
 ≥247 – 1.1 (0.7, 1.7)
 p (trend) – 0.87
Cooked processed meat (grams per week)
 0– <38 – 1.0 (ref.)
 38– <87 – 1.3 (0.9, 1.8)
 87– <165 – 1.3 (0.9, 1.8)
 ≥165 – 1.2 (0.7, 2.1)
 p (trend) – 0.33
Lunchmeat (grams per week)
 None – 1.0 (ref.)
 1– <33 – 0.9 (0.6, 1.4)
 33– <56 – 1.1 (0.8, 1.7)
 ≥56 – 1.0 (0.7, 1.5)
 p (trend) – 0.83
Poultry (grams per week)
 0– <91 – 1.0 (ref.)
 91– <164 – 0.9 (0.6, 1.3)
 164– <279 – 0.9 (0.6, 1.2)
 ≥279 – 0.7 (0.4, 1.1)
 p (trend) – 0.10
Fat intake
 Whittemore, 1995a Dietary fat intake (g/day)
 Quintile 1 (Median = 40.4) 1.0 (ref.) 1.0 (ref.)
 Quintile 2 (Median = 56.6) 0.53 (0.23, 1.2) 0.67 (0.31, 1.5)
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 Quintile 3 (Median = 73.6) 0.62 (0.29, 1.3) 1.6 (0.77, 3.3)
 Quintile 4 (Median = 95.9) 0.68 (0.34, 1.4) 1.3 (0.64, 2.7)
 Quintile 5 (Median = 140.1) 1.1 (0.57, 2.2) 1.8 (0.89, 3.7)
 p (trend) 0.42 0.36
Saturated fat intake (g/day)
 Quintile 1 (Median = 11.2) 1.0 (ref.) 1.0 (ref.)
 Quintile 2 (Median = 16.7) 0.51 (0.21, 1.2) 0.91 (0.40, 2.1)
 Quintile 3 (Median = 22.8) 0.57 (0.23, 1.4) 0.94 (0.41, 2.2)
 Quintile 4 (Median = 30.1) 0.82 (0.34, 2.0) 2.0 (0.80, 4.9)
 Quintile 5 (Median = 45.5) 1.4 (0.48, 4.2) 2.4 (0.72, 7.7)
 p (trend) 0.08 0.17
 Hayes, 1999 Foods high in animal fat (times/week)
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.6 1.6
 Quartile 3 4.0 (p < 0.05) 2.2 (p <0.05)
 Quartile 4 2.4 (p < 0.05) 2.1 (p <0.05)
 p (trend) 0.004 0.01
Fat (g/day)
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.9 (p < 0.05) 0.9
 Quartile 3 2.3 (p < 0.05) 1.5
 Quartile 4 2.4 (p < 0.05) 1.6
 p (trend) 0.002 0.04
Animal fat
 Quartile 1 (≤33) 1.0 (ref.) 1.0 (ref.)
 Quartile 2 [34-46] 2.2(p <0.05) 2.1 (p <0.05)
 Quartile 3 [47-61] 4.3 (p < 0.05) 2.4 (p <0.05)
 Quartile 4 (≥62) 3.3 (p < 0.05) 2.1 (p <0.05)
 p (trend) 0.0001 0.02
Other Fat (g/day)
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.3 1.1
 Quartile 3 1.5 1.5
 Quartile 4 1.3 1.7
 p (trend) 0.18 0.07
Other nutrients, vitamins, etc.
 Hayes, 1999 Protein (g/day)
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 2.1 (p < 0.05) 0.7
 Quartile 3 2.9 (p < 0.05) 1.1
 Quartile 4 2.6 (p < 0.05) 1.0
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Study Exposure Results
African American White
 p (trend) 0.0006 0.34
Carbohydrates (g/day)
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 0.8 1.3
 Quartile 3 1.4 1.3
 Quartile 4 1.7 (p < 0.05) 1.3
 p (trend) 0.002 0.71
Vitamin A: animal sources
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.4 1.1
 Quartile 3 1.5 1.0
 Quartile 4 1.7 0.9
 p (trend) 0.25 0.62
Vitamin A: fruit and vegetable sources
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.1 1.3
 Quartile 3 1.4 0.8
 Quartile 4 1.5 0.7
 p (trend) 0.23 0.08
Calcium: food sources
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.0 0.7
 Quartile 3 1.1 1.0
 Quartile 4 0.8 0.9
 p (trend) 0.44 0.90
Lycopene sources: combined food groups
 0–3 servings/mo 1.0 (ref.) 1.0 (ref.)
 1 serving/wk 1.5 1.4
 2–4 servings/wk 1.4 1.0
 5 + servings/wk 1.0 1.0
 p (trend) 0.14 0.54
Use of multivitamins
 No 1.0 (ref.) 1.0 (ref.)
 Yes 0.8 (0.5, 1.2) 0.8 (0.5, 1.3)
Dairy, grains, miscellaneous foods
 Hayes, 1999 Breads, grains, and cereals
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.0 0.9
 Quartile 3 1.2 0.9
 Quartile 4 1.7 0.9
 p (trend) 0.03 0.63

















 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.2 1.4
 Quartile 3 1.5 1.2
 Quartile 4 1.1 1.7
 p (trend) 0.57 0.07
Sweets
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 0.6 1.4
 Quartile 3 1.2 1.4
 Quartile 4 1.2 2.2 (p <0.05)
 p (trend) 0.15 0.006
Calories from food
 Quartile 1 1.0 (ref.) 1.0 (ref.)
 Quartile 2 1.3 1.4
 Quartile 3 2.4 (p < 0.05) 1.6
 Quartile 4 2.2 (p < 0.05) 1.5
 p (trend) 0.0004 0.16
Family history
 Hayes, 1995 Family history of prostate cancer
 No 1.0 (ref.) 1.0 (ref.)
 Yes 3.4 (1.3, 9.3) 2.1 (0.9, 4.5)
ref. referent group, BMI body mass index. Dashes (−) indicate results could not be calculated due to small numbers or were not provided in original
report
Advanced prostate cancer was defined differently between studies but based on cancer stage (i.e., regional/distant cases) and/or grade (i.e., cells
were poorly differentiated) in all instances
*
Indicates cohort study; all others were case–control studies
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